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Abstract: Telocyte (TC) is an interstitial cell type with a small cellular body and extremely long tenta-
cle-like extensions. TCs were discovered a decade ago and have specifi c morphological characteristics, 
immunohistochemical and secretome profi les, electrophysiological properties, microRNA expression. 
Moreover, they are diff erent in gene expression from other cells. TCs play an important role in plenty 
of processes. Apparently, they are involved in homeostasis, remodelling, regeneration, repair, embryo-
genesis, angiogenesis and even tumorigenesis. “Telocytes need the world”, was emphasized by Profes-
sor Popescu and it will be actual at any time. Th is review summarizes particular features of TCs in 
diff erent organs and systems, emphasizing their involvement in physiological and pathophysiological 
processes.
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History
About one decade ago, there has been discovered a  novel cell type with unique 
morphology and functions. L.M. Popescu’s group from Bucharest, Romania, focused 
on interstitial (stromal) cells in the connective tissue of many organs of humans 
and laboratory mammals, which named interstitial Cajal-like cells (ICLC) in 2005. 
A few years later, in 2008, M.S. Faussone-Pellegrini and her team from Florence, Italy, 
described ICLC in the muscle coat of the human gut and noticed they consistently 
diff ered from the canonical gastrointestinal cells of Cajal (ICC) in both ultrastructure 
and immunophenotype. In 2010 the acronym ICLC was replaced with a  more 
appropriate name one and introduced to scientifi c world for the fi rst time in the 
paper “TELOCYTES − a  case of serendipity: the winding way from Interstitial Cells of 
Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to TELOCYTES” in the Journal of 
Cellular and Molecular Medicine. From that time, this novel cell type became known 
as the TCs (using the Greek affi  x “Telos”). Nowadays, all cell name’s synonyms (ICLC, 
fi broblast-like cells, telocytes) are widely used in publications [1–4]. 
Morphology of telocytes
Th e TC has a  small, oval-shaped cellular body, containing nucleus, surrounded by 
a small amount of cytoplasm. Th e cellular body average dimensions are, as measured 
on TEM images: 9.39 μm ± 3.26 μm (min = 6.31 μm; max = 16.42 μm). Th e nucleus 
occupies about 25% of the cell volume and contains clusters of heterochromatin 
attached to the nuclear envelope. 
Th e perinuclear cytoplasm is rich in mitochondria (which occupy about 5% of the 
cell body) particularly in podoms, which contain a small Golgi complex, as well as the 
elements of rough and smooth endoplasmic reticulum and cytoskeletal elements (thin 
and intermediate fi laments). Th e cell periphery is represented by the usual plasmalemma, 
with no (or thin and discontinuous) basal lamina, and some caveolae (about 2–3% of 
cytoplasmatic volume; ~0.5 caveolae/μm of cell membrane length) [1–7]. 
Telocytes have a variable number of telopodes (Tps) (very long cellular extensions), 
which are probably the longest cellular prolongations in the human body. Tps are 
made by an alternation of dilated portions, named podoms (250–300 nm), containing 
mitochondria and endoplasmic reticulum and podomers (~80 nm) with thin 
segments. Th e podomers are thicker in nonpregnant myometrium than in pregnant 
one (~82 versus 75 nm), and the podoms were thicker in pregnant myometrium 
(~316 versus 269 nm) [1, 2, 5]. Th e shape of the TCs depends on the number of 
their telopodes (Tps): piriform for one prolongation, spindle for two Tps, triangular 
for three, stellate, etc. Th eir spatial appearance is that of a polyhedron with a diff erent 
number of vertices, depending on their Tps number [8]. 
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Tps form a  three-dimensional network that may function as a  scaff old to defi ne 
the correct organization of tissues and organs [9]. Mandache et al. mentioned that 
telopodes develop a  wrapping activity gathering masses of amyloid fi brils, partially 
or totally surrounding them. Th ese cellular ‘bags’ made by telopodes have sometimes 
inner cytoplasmic processes with honeycomb-like appearance which fragments in 
bunches the amyloid fi brils [10]. 
 Huizinga et al. proposed eight basic ultrastructural criteria for TC identifi ca-
tion in 1997 (“gold standard”). Later Popescu and his group added two more criteria 
and formed “platinum standard” of diagnosis for TCs [3, 11, 12].
 1. Location: among tubulo-alveolar structures, in the non-epithelial space
 2. Close contact with target: nerve bundles, and/or epithelia, and/or smooth muscle 
cells, and/or capillaries, immunoreactive cells by “stromal synapses”
 3. Characteristic cytoplasmic processes  
a. Number: (1–5, frequently: 2–3)
b. Length: tens to hundreds of μm
c. Th ickness: uneven caliber, <0.5 μm with dilations, but very thin from the 
emerging point
d. Aspect: moniliform, usually with mitochondria in dilations 
e. “Ca2+ release units”: present
f. Branching: dichotomous pattern
g. Organization in network: labyrinthine system of overlapping cytoplasmic 
processes
 4. Gap junctions: with smooth muscle cells or with each other
 5. Basal lamina: occasionally present
 6. Caveolae: 2–4% of cytoplasmic volume; ~0.5 caveolae/μm of cell membrane length
 7. Mitochondria: 5–10% of cytoplasmic volume
 8. Endoplasmic reticulum: about 1–2% of cytoplasmic volume, either smooth or rough
 9. Cytoskeleton: intermediate and thin fi laments, as well as microtubules
10. Myosin thick fi laments: undetectable
Some characteristics (morphology and density) of telocytes change with aging and 
some conditions. For instance, amount of TCs is decreasing in liver fi brosis, mirroring 
the recent fi ndings as described in the colonic wall in ulcerative colitis, the terminal 
ileum of patients aff ected by small bowel Crohn’s disease, and skin, gastric wall, lung 
and myocardium in systemic sclerosis [13, 14]. In pregnant uteri endometrial TCs 
increase, compared with non-pregnant, in spite of a signifi cant decline in the number of 
myometrial TCs. Postpartum uteri show the highest signifi cant count of myometrial TCs 
and non-signifi cant diff erence in endometrial TC count, as compared with the adult non-
pregnant group [15, 16]. Alunna et al. revealed that telocytes were markedly reduced in 
minor salivary glands from primary Sjögren’s syndrome patients compared to normal and 
8 Veronika Aleksandrovych, Artur Pasternak, et al.
non-specifi c chronic sialadenitis of minor salivary glands. Such a decrease was associated 
with both worsening of glandular infl ammation and progression of ectopic lymphoid 
neogenesis [17]. Li et al. mentioned that TCs in vasculature could appear with slightly 
modifi ed morphology, with more spherical, shorter and thicker prolongations [18].
Cantarero et al. have identifi ed in TCs the presence of a  single non-motile cilium 
called primary cilium. Primary cilia contain a  9+0 axoneme, consisting of nine outer 
doublet microtubules but lacking the central pair of microtubules. Except for nodal cilia, 
primary cilia are thought to lack axonemal dyneins and be immotile. Primary cilia in 
TCs might play a role in signalling processes within the vascular niche [19]. Moreover, 
in arterioles, TCs oft en send Tps bordering the tunica adventitia, while in venules and 
capillaries, they were located parallel with the longitudinal axis of the smooth muscle cells 
of the vessel wall [19]. Th e density of TCs in blood vessels is diff erent, by region [18].
Distribution of telocytes
Telocytes have been found in a  large variety of organs and are distributed in 
vertebrates (fi sh, reptiles, birds, mammals, including human) (Table 1) [5, 9, 15]. 
Table 1. Localization of telocytes in various organs.
Organ Localization of telocytes
Blood vessels (coronary 
arteries, internal thoracic 
arteries and carotid arteries)
on the endothelial surface [19, 20]
Bone marrow in close spatial relationships with small blood vessels and/or 
capillaries [20]
Canine dura mater closed to capillary and surrounded by a great deal of collagen fi bers [9]
Duodenum in the lamina propria, immediately below mucosal crypts [19]
Endocardium in the subendothelial layer, between the endocardial endothelium 
and the cardiomyocytes bundles [21–23]
Endometrium in the human endometrial stroma of the stratum functionalis and in 
the basal endometrium aft er menstruation [24–27]
Epicardium in human subepicardial area, in between collagen fascicles, in 
the neighbourhood of a cardiomyocyte [28]
Esopagus in lamina propria of human oesophageal mucosa, submucosa, as well 
as in muscular layer, in the adventitia [29, 30]
Exocrine pancreas in close proximity with both secretory acini and exocrine epithelial 
ducts and regulatory nerves and blood vessel apparatuses [31–34]
Eye in limbus, sclera and uvea of eye [35]
 Telocytes: facts, speculations and myths 9
Organ Localization of telocytes
Fallopian tube in mucosa and muscular layer among smooth muscle fi bres [3, 11, 36]
Fascia lata between collagen fi bers [37]
Gallbladder in the muscularis propria and in the bile ducts [38–40]
Heart valves in the interstitial layer of human cardiac valves in all three valve 
types (mitral, tricuspid and aortic), in both apex and base of heart 
valves [41]
Ileum in the in the muscularis and the lamina propria [42]
Jejunum in the lamina propria of jejunum just beneath the epithelial layer 
of the mucosal crypts and in between the smooth muscle cells of 
muscularis mucosae [43]
Kidney around renal tubules and vessels in the kidney cortex interstitium (in 
sub-capsular space) [44–46]
Liver in the Disse space of the liver [47]
Lungs in interstitial space of a intralobular bronchiole, in terminal and 
respiratory bronchioles, in alveolar ducts [48, 49]
Mammary gland in non-epithelial tissue compartments [50–52]
Meninges and choroid plexus in the vicinity of putative stem cells [53]
Mesentary in the vicinity of and intermingled with capillaries, nerve bundles, 
adipocytes and other interstitial cells, mainly macrophages and 
fi broblasts [54]
Minor salivary glands formed an almost continuous layer encircling both the excretory 
ducts and the secretory units [17]
Myocardium TCs represent a small fraction of human cardiac interstitial cells 
[55–60]
Myometrium in the myometrial interstitium [15, 61, 62]
Neuromuscular spindles form the innermost and (partially) the outermost layers of the NMS 
capsule, and the internal capsule [63]
Parotid glands around ducts of various calibers [64]
Placenta in the large stem villi, with their long, slender process surrounding 
the blood vessel wall, or interposed between arterioles and the 
trophoblast basement membrane in small stem villi [65–67]
Pleura in human parietal pleura, the sub-mesothelial space contained 
numerous telocytes [68]
Prostate in prostatic stroma, especially in the adjacent epithelial area [69]
Pulmonary vein at the internal limit of the myocardial sleeves, parallel with the long 
axis of the pulmonary vein [70]
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Organ Localization of telocytes
Renal pelvis in the lamina propria [71]
Skeletal muscles in interstitium: [72, 73]
Skin in dermis [74]
Spleen in red pulp [75]
Temporomandibular joint disc closed to collagen bundles [76]
Testis in the outer layer around peritubular cells [77]
Th oracic duct subendothelial region of the wall as well as in intimate association 
with smooth muscle bundles throughout the media [78]
Trachea among smooth muscle fi bers and endothelium [48, 79]
Trigeminal ganglion in close vicinity to microvessels and nerve fi bers around the 
neuronal-glial units (NGUs) [80]
Urethra in the lamina propria [71]
Ureters in the lamina propria, mainly exist in between smooth muscle 
bundles [45, 81, 82]
Urinary bladder in the lamina propria [45, 83]
Vicinity of telocytes and its secretomes
TCs demonstrate specifi c direct (homocellular and heterocellular junctions) and/or 
indirect (chemical, paracrine/juxtacrine signalling, microvesicles and exosomes, sex 
hormone and microRNAs) contacts with various surrounding cells. Homocellular 
junctions allow TCs to keep an architecture of tissue, generating 3D (three-
dimensional) networks. Moreover, they contain elements of the cytoskeleton such as 
microfi laments, microtubules and vimentin [3]. Connections between TCs-exosomes-
intercellular junctions cytoskeleton form the equivalent of a primitive nervous system 
[84]. In the heart TCs make contacts with diff erent morphology (puncta adhaerentia 
minima, processus adhaerentes and manubria adhaerentia) [22, 23]. In the TCs 
the most represented are the nexuses (gap junctions), that are known to allow the 
exchanges of metabolites and signals [2, 7].
Heterocellular contacts TCs make with a  variety of cells: smooth muscle cells, 
nerves, immunocytes (macrophages, mast cells and lymphocytes), stem cells, 
melanocytes in the eye [35], erythrocytes in the spleen [75] and with Schwann cells 
in the heart [23]. Gherhiceanu et al. reported that TCs make contact with virtually 
all types of cells in the human heart. His team suggested that heterocellular contacts 
occur by means of minute junctions (point contacts, nanocontacts and planar contacts) 
Table 1. Cont.
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and the mean intermembrane distance is within the macromolecular interaction range 
(10–30 nm) [23]. Moreover, TCs establish close contacts, stromal synapses (connective 
connections), with tracheal mast cells and in the trigeminal ganglion [79, 80]. 
Telocytes release at least three types of extracellular vesicles: exosomes 
(45 ± 8 nm), ectosomes (128 ± 28 nm) and multivesicular cargos (1 ± 0.4 μm) from 
their Tps and, occasionally, from the cell body [6, 85]. Yang et al. observed that the 
vascular TCs secreted more vesicles and bands in the Tps than the TCs that were 
located within other structures. Th e presence of a  large number of vesicles appears 
to be a conserved feature of TCs regardless of their location [77]. Th ese cells secrete 
interleukins (IL-2, IL-6, IL-10 and IL-13), growth factors (VEGF and EGF), nitric 
oxide, macrophage infl ammatory protein 1α and 2 (MIP-1α and MIP-2), Monocyte 
Chemoattractant Protein 1 (MCP-1), Growth-Related Oncogene/Keratinocyte-derived 
Chemokine (GRO-KC). Th ree major classes of elements in telocyte secretomes include 
growth factors, chemoattractants, and cytokines/chemokines, indicating that telocytes 
may   regulate stem cell growth and diff erentiation, microenvironmental formations 
 [86–89]. Yang et al. revealed the presence of TCs that were directly connected 
to Leydig cells, which suggests that TCs are indirectly involved in the secretion of 
testosterone, rostenedione and dehydropiandrosterone [77].
Telocytes and its genes, proteins and microRNAs
Th e four diff erent studies were conducted on gene expression profi le of TCs in the 
last two years. Researchers focused on TCs-specifi c or TCs-dominated gene profi les 
in chromosome 1, 2, 3, 17 and 18 using global comparison between TCs and other 
cell types found in the mouse lung tissue [90]. TCs had a  strong number of up- and 
down-regulated genes in all patterns (Table 2). Important to note that amount 
of down-regulated genes was 2–3 times higher than up-regulated in all observed 
chromosomes. 
Table 2. Number of up-regulated and down-regulated genes in chromosomes of telocytes.
Chromosome Number of up-regulated genes Number of down-regulated-genes
 1 14 39
 2 26 80
 3 13 59
 4 17 56
17 16 68
18 10 22
(Date: 19.06.2016)
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Aft er analysis of up-regulated genes functions in TCs, it had been mostly suggested 
that these cells are involved in cellular signaling, cell expansion and movement 
(migration, adhesion, migration and division), embryogenesis, morphogenesis and 
tissue homoeostasis (including immune homeostasis), tissue remodelling and repair, 
maintenance of oxidative microenvironment preventing tumorigenesis and anti-
infl ammatory responses [90–96].
Zheng et al. provided the fi rst proteomic analysis on TCs and showed these cells 
are exactly diff erent from the protein expression point of view. In TCs proteins were 
mainly located in the cytoplasmic compartment and involved in cell signalling, energy 
and metabolic pathways. Myosin-14, periplakin and envoplakin, SOD2 (SODM), 
acid ceramidase were up-regulated in TCs. Several proteins up-regulated in TCs 
were found among the top 100 vesicular proteins that are present most frequently in 
mammalian extracellular vesicles proteome [92, 96]. 
TCs express signifi cant amount of pro-angiogenic microRNAs (miR126, miR130a, 
let-7-family, miR-10, miR-155, miR-503, miR-126, miR-27b, miR-503, and  miR-100), 
also miR-21, miR-22, miR-29 and miR-199a, both stromal specific and vascular 
smooth muscle specifi c (miR-143/145). Th ese cells do not express miR-193 and have 
lack of expression of cardyomyocyte-specifi c miRs (miR-1 and miR-133a or miR-208) 
[2, 60, 97, 98].
Immunohistochemical features
Nowadays immunohistochemistry combined with TEM is the most applicable method 
to identify TCs (Table 3). Despite the fact that has not yet been found a  specifi c 
marker for TCs, usually for primary identifi cation scientists use CD34 [99]. Important 
to note that CD117/c-kit has been excluded for some organs or its parts [99] and 
diff ers between TCs populations (possible site dependant) [2, 6, 100]. For instance, rat 
uterus tissue contains diff erent types of immune positive TCs: c-kit (–)/vimentin (+), 
c-kit (+)/vimentin (+), c-kit (+)/CD34 (+), while in human dermal tissue TCs were 
c-kit (–)/CD34 (+)/CD31 (–) [101, 102]. Th is range might be the basis of region-
specifi c TCs roles [6, 103]. 
Table 3. Immunohistochemical profi le of telocytes.
Positive Negative
CD34, CD117/c-Kit, plated-derived growth factor 
receptor alpha and beta (PDGFRα and-β), VEGF, 
inducible nitric oxide synthase (iNOS), calveolin-1, 
vimentin, connexin 43, oestrogen and progesterone 
receptors (PRs), CD44, desmin, nestin, cadherin-11, 
CD29, CD10
Procollagen 1, CD31/PECAM-1, α-smooth 
muscle actin (α-SMA), CD11c, CD90/Th y-1, 
CD68, CD1a, CD62-P, CD45
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Th e best available choice is a combination of four immunohistochemical markers: 
CD34, c-kit, vimentin and PDGFRα [4, 14, 103]. However, for diff erential diagnosis 
between TCs and other cells is oft en used a  double immunolabelling [100, 104]. 
Compare cardiac TCs with cardiac fi broblasts and pericytes, Bei et al. demonstrated 
that cardiac TCs are CD34/c-kit, CD34/vimentin and CD34/PDGFR-β positive and 
α-SMA weak positive, while cardiac fibroblasts are only vimentin and PDGFR-β 
positive and pericytes are CD34 negative, α-SMA and PDGFR-β positive [104, 105]. 
Endoneurial fi broblasts are CD34 positive [7, 106].
Zhou et al. experimentally showed a high expression level for PDGFR-α compare 
with PDGFR-β in cardiac TCs [102]. Th e double immunofl uorescent staining for 
CD34 and PDGFR-α is considered to be a specifi c immunohistochemical marker for 
TCs in gastrointestinal tract [100, 107]. 
TCs inconstantly express stem cell markers such as Sca-1 (Stem cell antigen-1) 
and Oct4 (octamer-binding transcription factor 4) [2]. Chang et al. depicted that 
splenic TCs express nanog (a transcription factor critically involved with self-renewal 
of undiff erentiated embryonic stem cells) and Sca-1, while c-kit negative [44]. Using 
fl ow cytometry analysis, Bei et al. showed that TCs were homogenously positive for 
mesenchymal marker CD29 but negative for hematopoietic marker CD45, which is 
similar to bone marrow-derived mesenchymal stem cells [105]. In addition, as CD34+ 
cells may lose CD34 expression and acquire other marker expressions “in vivo” and 
“in vitro” [105, 108]. Petre et al. found that TCs in the mammary gland stroma were 
CD10±/c-kit-/vimentin+ [109, 110]. 
Electrophysiological characteristics
Recently, studies on the electrophysiological properties of TCs have shown various 
types of ionic channels in diff erent organs (transient outward and inward currents). 
In diff erent organs TCs have been shown to possess diff erent types of potassium, 
chloride and calcium channels.
Lee et al. found that TCs in murine detrusor muscle express small-conductance 
Ca2+-activated K+ channels, most prominently the SK3 isoform, whereas expression 
of SK channels was low in smooth muscle cells [111]. It followed that SK channel 
regulation of bladder excitability was likely mediated through TCs rather than through 
SMCs. Moreover, SK3 channels have been identifi ed in the myometrium and in the 
glandular and luminal epithelium of the endometrium [112]. Kim et al. showed the 
presence of calcium-activated potassium channels in stomach [3, 113, 114]. Cretoiu 
et al. suggested that rhythmical intracellular calcium discharges originating in TCs 
contribute to the pacemaker activity [3]. 
Sheng et al. firstly demonstrated that cardiac atrial and ventricular TCs ex-
pressed large conductance Ca2+-activated K+ current (BKCa) and inwardly rectifying 
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K+   current (IKir), but not transient outward K+ current (Ito) and ATP-sensitive potas-
sium current (KATP) [115]. 
In human myometrium, patch-clamp recordings of TCs revealed a  calcium-
dependent hyperpolarization-activated chloride inward current, but absence of L-type 
calcium channels, which was postulated to modulate myometrial smooth muscle 
contractions [3, 115]. Rosenbaum et al. observed small-conductance calcium-activated 
potassium currents in human myometrium and concluded that its expression is 
higher in non-pregnant compared to pregnant tissue [116]. A similar situation 
with SK3 expression in vascular endothelium is found during pregnancy. Th ese are 
also expressed in TCs and are down-regulated during pregnancy when they reduce 
contractility [6, 117]. 
T-type calcium channels are present in TCs from human myometrium, which 
in pregnancy and labour participate in the generation of endogenous bioelectric 
signals responsible for the regulation of the surrounding cell behaviour. It might be 
the missing link for describing the molecular mechanisms by which TCs are involved 
in mechanical stretching during uterine enlargement in pregnancy. Th e expression 
of α-subunit of T-type calcium channels in TCs is less intense in the case of non-
pregnant myometrium [6, 118]. Steroid hormones and oxytocin might mediate 
the higher expression of T-type calcium channels in TCs derived from pregnant 
myometrium. As TCs have steroid hormone receptors, this might lead to frequent 
and sustained contractions that are able to trigger birth [6]. In fetal cardiac myocytes, 
T-type Ca2+ channels were suggested to play role in the regulation of cardiomyocyte 
size [118]. 
TCs have diff erences in reactivity to the low-level laser stimulation (LLLS). In 
pregnant myometrium primary cultures a growth rate of lateral telopodal extension 
of TCs is higher than in non-pregnant ones. Twenty-five percent of TCs from 
pregnant uterus present a local thickening of the TP upon LLLS. Th e local thickening 
phenomenon was directly correlated with a delayed telopodal response to stimulation 
[119]. C-kit inhibition by imatinib (receptor antagonist) led to a  reduction in both 
the amplitude and frequency of myometrial contraction in a dosedependent manner. 
TCs might be players in the coordination of uterine activity in a  kit-independent 
manner [25, 120]. 
Myometrial TCs have large input resistance, ranging between 1.2 and 12  GΩ. 
Th ey failed to produce the regular slow waves of depolarization described in classical 
ICCs, although some irregular excursions of membrane potential ranging from 10 to 
35 mV have been observed by Duquette et al. TCs did not generate action potentials 
in response to depolarizing current. Only passive electric potentials were recorded 
when current pulses were applied [105].
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Possible role of TCs
Nowadays, more researchers focus on intercellular communication of TCs and its roles 
in cells niche. Th e number of publications is gradually rising, refl ecting the importance 
of these cells. Sometimes at the beginning, data might be slightly speculative, but later 
they can be empiric proved. Likewise, more attention to attract connection TCs with 
smooth muscle cells, nerve endings, vessels and stem cells. Th ey play a  key role in 
a variety of pathological processes (myocardial infarction, heart failure, renal ischemia-
reperfusion injury, liver fi brosis and others) and adaptive responses [121–125]. 
TCs might behave as an immune system modulator interrelating immune cells 
in interstitium context and providing functional support [30]. For instance, TCs are 
major cell type of the human thoracic duct [78]. Th e importance of TCs in normal and 
pathological immune response is faceted, proved by diff erent point of view. Ardeleanu 
et al. proposed that TCs could be the common cells of origin for both perivascular 
epithelioid cell tumours (PEComas) and gastro-intestinal stromal tumours (GISTs) 
[34, 121]. Mou et al. proposed that stromal cells containing TCs might infl uence the 
self-assembly of reconstituted breast cancer tissue [51]. Mandache et al. considered 
that TCs might play an important role in amyloid deposits formation [10]. Important 
to note, TCs can be a structural and functional unit of main immunological barriers 
in the human organism. Yang et al. suggested that TCs play important roles in the 
blood-testis barrier [77], whereas Gherghiceanu et al. proposed involving TCs in 
“blood–myocardium barrier” as they the main population in the sub-epithelial layer 
of endocardium [21].
Th e tandem telocytes-stem cells has been found in stem-cell niches in various 
organs (e.g. epicardium, lungs, skeletal muscle, choroid plexus, skin) [35, 122, 123]. 
Cantarero et al. proposed TCs with nerve fibers and blood vessels form such 
functional unit as “‘mesenchymal cell niche” [19], while Luesma et al. suggested that 
there are two diff erent types of stem-cell niches into the eye: epithelial niches (basal 
cells in cornea and conjunctiva) and stromal niches (iris, corneoscleral junction). 
Th e TCs network could even be a scaff old for stem cells migration between diff erent 
layers of the eye [35]. Moreover, a  study, made by Gherghiceanu and Popescu in 
2009, has suggested that TCs are involved in mesothelial renewal and might guide 
the migration of mesenchymal cells into the mesothelial layer of the epicardium [28]. 
According to Petre et al. TCs “could be actors in the mammary stem niche” [43, 109]. 
Splentic TCs could take part in formation of splenic hematopoietic niche and play 
important role in transmitting the signals [75]. Alunna et al. suggested that a  loss of 
minor salivary glands telocytes might have important pathophysiological implications 
in primary Sjögren’s syndrome [17]. 
Telocytes are located in the neuromuscular spindles and participate in the control 
of muscle tone and motor activity. Th ey produce electric slow waves that trigger and 
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coordinate smooth muscle contractions in the uterus. Th e decreasing in TCs caused 
dysregulation of oviduct motility, suggesting that tubal TCs impairment leads to the 
infertility of tubal origin and even tubal ectopic pregnancy [103, 126, 127]. Matyja 
et al. showed that a  reduction in TC number may be a  consequence of the toxicity 
of the supersaturated bile, while some other bile components (glycocholic and 
taurocholic acids) may exert protective eff ects on TCs and thus possibly infl uence the 
mechanisms regulating gallbladder and extrahepatic bile duct motility [39, 128–130]. 
Fu et al. found that hepatic TCs were signifi cantly decreased by 27%–60% in human 
liver fi brosis, suggesting that loss of TCs might lead to the altered organization of 
extracellular matrix [13]. 
Telocytes have a  powerful potential in tissue repair and regeneration (in heart, 
lung, skeletal muscle, skin, meninges and choroid plexus, eye, liver, uterus and urinary 
system) [131, 132]. It might be a  future target for therapeutic value in preventing of 
diseases. In conclusion, it is not superfl uous to emphasize the importance of new 
studies, that allow us better understanding the nature of Telocytes.
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